Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04208087 · ClinicalTrials.gov registry record · Phase 1
PK and Safety of SI-722 in IC/BPS
A Phase 1 study, sponsored by Seikagaku Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
NCT04208087 is a Phase 1 study that has completed, run by Seikagaku Corporation. The registered enrollment target is 33 participants.
The verdict
NCT04208087, a Phase 1 study, has completed, sponsored by Seikagaku Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
This study is designed randomized, double-blind, placebo-controlled trial in Interstitial Cystitis/Bladder Pain Syndrome patients.
Interventions
- DRUG Placebo
- DRUG SI-722
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2020-03-30 |
| Est. Completion | 2021-01-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04208087
The ClinicalTrials.gov registry entry for NCT04208087 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seikagaku Corporation, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04208087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04208087 about?
NCT04208087 is a clinical study titled "PK and Safety of SI-722 in IC/BPS". This study is designed randomized, double-blind, placebo-controlled trial in Interstitial Cystitis/Bladder Pain Syndrome patients.
What is the current status of trial NCT04208087?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2020-03-30. Estimated completion is 2021-01-12.
What interventions are being tested in trial NCT04208087?
The interventions under investigation include: Placebo (DRUG), SI-722 (DRUG).
Who is sponsoring clinical trial NCT04208087?
This trial is sponsored by Seikagaku Corporation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.